| DC Field | Value | Language |
|---|
| dc.contributor.author | Avdeeva, N. V. | - |
| dc.date.accessioned | 2022-05-04T11:19:29Z | - |
| dc.date.available | 2022-05-04T11:19:29Z | - |
| dc.date.issued | 2020 | - |
| dc.identifier.citation | Avdeeva, N.V. Novel mGluR4 agonist Rapitalam ameliorates motor dysfunction in mice with tau-associated neurodegeneration / N.V. Avdeeva // Research Results in Pharmacology. - 2020. - Vol.6, №2.-P. 9-17. - Doi: 10.3897/rrpharmacology.6.52098. | ru |
| dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/46574 | - |
| dc.description.abstract | Tau protein is classically involved in the pathogenesis of a neurodegenerative processes, such as Parkinson’s disease. This study was aimed at testing the novel mGluR4 selective agonist using it in transgenic mice with tau-associated neurodegeneration | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | Tau protein | ru |
| dc.subject | neurodegeneration | ru |
| dc.subject | Rapitalam | ru |
| dc.subject | mGluR4 | ru |
| dc.subject | frontotemporal dementia | ru |
| dc.subject | parkinsonism | ru |
| dc.title | Novel mGluR4 agonist Rapitalam ameliorates motor dysfunction in mice with tau-associated neurodegeneration | ru |
| dc.type | Article | ru |
| Appears in Collections: | Vol. 6, № 2
|
